Supercritical fluid technology for the development of innovative ophthalmic medical devices: Drug loaded intraocular lenses to mitigate posterior capsule opacification.


Journal

European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V
ISSN: 1873-3441
Titre abrégé: Eur J Pharm Biopharm
Pays: Netherlands
ID NLM: 9109778

Informations de publication

Date de publication:
Apr 2020
Historique:
received: 20 12 2019
revised: 17 02 2020
accepted: 24 02 2020
pubmed: 1 3 2020
medline: 1 12 2020
entrez: 1 3 2020
Statut: ppublish

Résumé

Supercritical impregnation technology was applied to load acrylic intraocular lenses (IOLs) with methotrexate to produce a sustained drug delivery device to mitigate posterior capsule opacification. Drug release kinetics were studied in vitro and used to determine the drug loading. Loaded IOLs and control IOLs treated under the same operating conditions, but without drug, were implanted ex vivo in human donor capsular bags. The typical cell growth was observed and immunofluorescence staining of three common fibrosis markers, fibronectin, F-actin and α-smooth muscle actin was carried out. Transparent IOLs presenting a sustained release of methotrexate for more than 80 days were produced. Drug loading varying between 0.43 and 0.75 ± 0.03 µg

Identifiants

pubmed: 32112896
pii: S0939-6411(20)30052-7
doi: 10.1016/j.ejpb.2020.02.011
pii:
doi:

Substances chimiques

Acrylic Resins 0
Delayed-Action Preparations 0
Solvents 0
Methotrexate YL5FZ2Y5U1

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

248-256

Informations de copyright

Copyright © 2020 Elsevier B.V. All rights reserved.

Auteurs

Kanjana Ongkasin (K)

Aix Marseille Univ, CNRS, Centrale Marseille, M2P2, Marseille, France.

Yasmine Masmoudi (Y)

Aix Marseille Univ, CNRS, Centrale Marseille, M2P2, Marseille, France. Electronic address: yasmine.masmoudi@univ-amu.fr.

Christian M Wertheimer (CM)

Laboratory for Cell Biology, Department of Opthalmology, Ludwig-Maximilians-University, Munich, Germany.

Anna Hillenmayer (A)

Laboratory for Cell Biology, Department of Opthalmology, Ludwig-Maximilians-University, Munich, Germany.

Kirsten H Eibl-Lindner (KH)

Laboratory for Cell Biology, Department of Opthalmology, Ludwig-Maximilians-University, Munich, Germany.

Elisabeth Badens (E)

Aix Marseille Univ, CNRS, Centrale Marseille, M2P2, Marseille, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH